The treatment of depressive disorders in epilepsy: what all neurologists should know (Q26851858)

language of work or name

1 reference

March 2013

1 reference

1 reference

54 Suppl 1

1 reference

PubMed

page(s)

3-12

1 reference

Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports

PubMed

cites work

1 reference

Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders

21 January 2018

1 reference

Cognitive-behavioral therapy for depression in patients with temporal lobe epilepsy: a pilot study.

21 January 2018

1 reference

Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures

21 January 2018

1 reference

The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis

21 January 2018

1 reference

21 January 2018

1 reference

Panic and suicidal ideation in primary care

21 January 2018

1 reference

Depression and suicide attempt as risk factors for incident unprovoked seizures

21 January 2018

1 reference

Epilepsy, suicidality, and psychiatric disorders: a bidirectional association.

21 January 2018

1 reference

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations

21 January 2018

1 reference

Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy.

21 January 2018

1 reference

Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?

21 January 2018

1 reference

International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy.

21 January 2018

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants

21 January 2018

1 reference

Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.

21 January 2018

1 reference

Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety.

21 January 2018

1 reference

Phenytoin intoxication induced by fluvoxamine

21 January 2018

1 reference

A randomized trial of a group based cognitive behavior therapy program for older adults with epilepsy: the impact on seizure frequency, depression and psychosocial well-being.

21 January 2018

1 reference

Treatment of anxiety disorders in epilepsy: an evidence-based approach

21 January 2018

1 reference

The role of titration schedule of topiramate for the development of depression in patients with epilepsy

21 January 2018

1 reference

Psychiatric adverse events during levetiracetam therapy

21 January 2018

1 reference

Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy.

21 January 2018

1 reference

Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors

21 January 2018

1 reference

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

21 January 2018

1 reference

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

Citalopram as treatment of depression in patients with epilepsy

21 January 2018

1 reference

Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs

21 January 2018

1 reference

Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables

21 January 2018

1 reference

Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth

21 January 2018

1 reference

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

Suicidal ideation in epilepsy and levetiracetam therapy

21 January 2018

1 reference

Antiepileptic drug interactions in patients requiring psychiatric drug treatment

21 January 2018

1 reference

Depression in epilepsy. Significance and phenomenology

21 January 2018

1 reference

7 January 2021

Major depression is a risk factor for seizures in older adults

1 reference

7 January 2021

The Use of Sertraline in Patients with Epilepsy: Is It Safe?

1 reference

7 January 2021

Treatment of Interictal Depression with Citalopram in Patients with Epilepsy

1 reference

7 January 2021

Residual symptoms after partial remission: an important outcome in depression

1 reference

7 January 2021

Persistent depression and anxiety in the United States: prevalence and quality of care

1 reference

7 January 2021

Anticonvulsant effect of fluoxetine in humans

1 reference

7 January 2021

release_owr6bvwte5fihlqrfu6be6ac24

Identifiers

DOI

10.1111/EPI.12100

0 references

Fatcat ID

0 references

PubMed publication ID

23458461

1 reference